courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) released its public equity holdings as of June 30, 2014. Warren Buffett’s different portfolio holdings have not been changing much of late, but it turns…
MannKind Corp. (NASDAQ: MNKD) was supposed to be a huge winner on this week’s news that Sanofi (NYSE: SNY) will become its global partner for its inhalable insulin Afrezza. There has been just one…
ThinkstockMannKind Corp. (NASDAQ: MNKD) was supposed to be in the news for its earnings report. Instead, we got news of its strategy on how to get its Afrezza inhalable insulin to the…
The Department of Defense awarded $409 million in defense contracts Friday. Hewlett Packard won the day's largest award. The company will continue to providing information technology services at nearly 2,500 Navy and…
courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has released its holdings as of the end of the first quarter of 2014. We were originally not expecting many major changes to the portfolio.…
White House Photo by Pete SouzaAfter finishing last year strong, U.S. equity markets had a volatile start this year, pulling back from all-time highs. Stocks have recovered since and, so far this…
courtesy of WhiteHouse.govNow that stocks have pulled back from their highs, some investors have moved on to more defensive stock positions. That move often lands some of the top dividend payers as…
White House Photo by Pete SouzaAs many consider Warren Buffett to be the greatest investor of modern times, investors want to know any time there are big changes in the Berkshire Hathaway…
These are the top analyst downgrades and cautious research notes from Wall Street for Monday, January 6.
White House Photo by Pete SouzaBerkshire Hathaway Inc. (NYSE: BRK-A) and Warren Buffett have released the conglomerate’s full stock holdings as of September 30, 2013. This 13F filing with the SEC shows…
ThinkstockThe wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company ViroPharma (NASDAQ: VPHM) in…
ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big pharmaceutical company’s R&D operations. Since the return on research investment at Merck…
ThinkstockViroPharma Inc. (NASDAQ: VPHM) has become the latest and greatest biotech buyout candidate after a report of it being a buyout candidate surfaced last week. We saw some 11 million shares trade…
Courtesy SanofiThe U.S. division of Paris-based Sanofi (NYSE: SNY) announced on Monday that an iconic U.S. consumer product not named Twinkies is on its way back to store shelves. Over-the-counter antacid Rolaids…
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the top companies…
